Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02234336 · ClinicalTrials.gov registry record
Assessment of Wall Thickness in Hypertrophic Cardiomyopathy
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 110
- Enrollment target
NCT02234336: Completed study, sponsored by Mayo Clinic.
NCT02234336 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02234336 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
Assessment of wall thickness in hypertrophic cardiomyopathy (HCM) is of diagnostic and prognostic importance given its known association with sudden cardiac death. However, data regarding comparison of imaging modalities for this key measurement is lacking. This study seeks to compare assessment of maximum wall thickness between clinically indicated echocardiography (with and without contrast) and clinically indicated cardiac magnetic resonance imaging.
Primary Outcome
All subjects will undergo noncontrast echocardiography, contrast echocardiography and cardiac MRI.
Interventions
- PROCEDURE Noncontrast echocardiography
- PROCEDURE Contrast Echocardiography
- PROCEDURE Cardiac magnetic resonance imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2014-10 |
| Est. Completion | 2017-07-25 |
What the finished NCT02234336 record still lists
NCT02234336 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Noncontrast echocardiography is the first listed.
NCT02234336 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02234336 about?
NCT02234336 is a clinical study titled "Assessment of Wall Thickness in Hypertrophic Cardiomyopathy". Assessment of wall thickness in hypertrophic cardiomyopathy (HCM) is of diagnostic and prognostic importance given its known association with sudden cardiac death. However, data regarding comparison of imaging modalities for this key measurement is lacking. This study seeks to compare assessment of ...
What is the current status of trial NCT02234336?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2014-10. Estimated completion is 2017-07-25.
What interventions are being tested in trial NCT02234336?
The interventions under investigation include: Noncontrast echocardiography (PROCEDURE), Contrast Echocardiography (PROCEDURE), Cardiac magnetic resonance imaging (PROCEDURE).
Who is sponsoring clinical trial NCT02234336?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia